trial · primary record
AGENT DCB 40 mm
In-Stent Restenosis
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2027-12 |
| Primary endpoint | Number of Participants With Target Lesion Failure |
| Registry ID | NCT06492174 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:07.193Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06492174
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.